FIELD: medicine.
SUBSTANCE: present group of inventions relates to medicine, namely to therapy, and concerns the prediction of the risk of developing hypertension. To do this, compare a level of soluble ST2 of a subject who does not have hypertension at the time of the study with a reference level of soluble ST2 determined in a healthy subject. When the level of soluble ST2 increases above the reference one, an increased risk of developing hypertension is diagnosed.
EFFECT: invention ensures a timely start of antihypertensive therapy.
19 cl, 1 ex, 2 tbl
Authors
Dates
2019-03-26—Published
2013-08-16—Filed